Defective catabolism of low-density lipoprotein by fibroblasts from patients with I-cell disease

Biochem J. 1982 Jan 15;202(1):183-90. doi: 10.1042/bj2020183.

Abstract

Skin fibroblast cultures from patients with I-cell disease (mucolipidosis II) are characterized by multiple lysosomal enzyme deficiencies The present studies deal with the consequences of these deficiencies with respect to the metabolism of plasma low-density lipoproteins. Degradation of the protein moiety was defective in I-cells compared with control cells, but the binding and internalization of low density lipoprotein were much less affected. Measurements of low-density lipoprotein degradation in homogenates demonstrated directly for the first time a deficiency of acid proteinase activity in I-cell fibroblasts. Comparison of results in 6-h incubations with those in 24-h incubations showed accumulation of intracellular low-density lipoprotein in I-cell fibroblasts and an accelerating rate of degradation, possibly attributable to intracellular accumulation of low-density lipoprotein substrate. The significance of these findings with respect to low-density lipoprotein metabolism in vivo is discussed.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cells, Cultured
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Hydroxymethylglutaryl CoA Reductases / metabolism
  • Hyperlipoproteinemia Type II / metabolism
  • Infant
  • Ketocholesterols / pharmacology
  • Lipoproteins, LDL / metabolism*
  • Lipoproteins, LDL / pharmacology
  • Mucolipidoses / metabolism*
  • Protein Binding
  • Skin / metabolism*

Substances

  • Ketocholesterols
  • Lipoproteins, LDL
  • Hydroxymethylglutaryl CoA Reductases
  • 7-ketocholesterol